⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 2, 2026

Gastrografin Röntgenkontrastmittel zur oralen und rektalen Anwendung (Lösung zur gastrointestinalen Anwendung)

📷 EU Safety Watch placeholder
Gastrografin Röntgenkontrastmittel zur oralen und rektalen Anwendung (Lösung zur gastrointestinalen Anwendung)
📷 EU Safety Watch placeholder
A recall has been issued for certain batches of Gastrografin, an X-ray contrast agent used orally or rectally.
⚠️
Shortage ongoing
AMIDOTRIZOESÄURE DIHYDRAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Gastrografin is a liquid used for X-ray pictures of the stomach and gut.

What's happening? Some packs of Gastrografin are being taken back from pharmacies.

Does this affect me? If you were given a pack after February 2026, it may be part of the recall.

What should I do? Ask your pharmacist or doctor if your pack needs to be checked.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
AMIDOTRIZOESÄURE DIHYDRAT
Agency-published detail

ATC: V08AA01 · Reason: Rückruf von Chargen am Markt · Marketing authorisation holder: Bayer Austria Ges.m.b.H., Am Europlatz 1, 1120 Wien, Österreich · BASG note: Informationen zum Rückruf unter https://www.basg.gv.at/marktbeobachtung/amtliche-nachrichten/detail/gastrografin-roentgenkontrastmittel-zur-oralen-und-rektalen-anwendung Information regarding the recall please see https://www.basg.gv.at/en/market-surveillance/official-announcements/detail/gastrografin-roentgenkontrastmittel-zur-oralen-und-rektalen-anwendung · Affected packs: 1 Stück Schachtel, Flasche [Nicht verfügbar, since 2026-02-13]

First published
March 2, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Gastrografin Röntgenkontrastmittel zur oralen und rektalen Anwendung (Lösung zur gastrointestinalen Anwendung). A recall has been issued for certain batches of Gastrografin, an X-ray contrast agent used orally or rectally.
▸ When was this alert issued?
This alert was issued on March 2, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.